COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo)
Clinical trial NCT04389385 · UNKNOWN
Trial details
- NCT number
- NCT04389385
- Sponsor
- TC Erciyes University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-09-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.